Risk factors and drug resistance of the MDR Acinetobacter baumannii in pneumonia patients in ICU
Authors:
Open Access
- 1 January 2019
- journal article
- research article
- Published by Walter de Gruyter GmbH in Open Medicine
- Vol. 14 (1) , 772-777
Abstract
Objective: To investigate the risk factors and drug resistance of MDR Acinetobacter baumannii in pneumonia patients. Methods: From January 2013 to February 2016, 98 pneumonia patients with MDR Acinetobacter baumannii in our hospital ICU were selected as the observation group, and 49 pneumonia patients with not-MDR Acinetobacter baumannii in our hospital ICU were selected as the control group in accordance with the proportion of 2:1. Sputum samples were collected from the two groups for drug resistance, and the risk factors and prognosis of MDR Acinetobacter baumannii in pneumonia patients were given survey analysis. Results: The observation group was highly resistant to cefotaxime, piperacillin, imipenem, levofloxacin, gentamicin, tetracycline and ceftazidime, and was only sensitive to polymyxin. In addition to piperacillin, polymyxin B, the other antimicrobial drug resistance rates in the control group was significantly lower than in the observation group (P<0.05). Univariate analysis showed that diabetes, infection before hospitalization, admission 24h score of APACHE II and GCS scores, deep venous catheterization, and mechanical ventilation were related to the MDR Acinetobacter baumannii in pneumonia patients(P<0.05). Non conditional logistic regression analysis showed that diabetes mellitus, infection before hospitalization, admission 24h score of APACHE II and GCS scores were the independent risk factors for the MDR Acinetobacter baumannii in pneumonia patients(P<0.05). Conclusion: MDR Acinetobacter baumannii in pneumonia patients in ICU is common, where diabetes infection before hospitalization, admission 24h score of APACHE II and GCS scores are the main risk factors, and the vast majority of the antibiotics are resistant to the MDR Acinetobacter baumannii that can lead to poorer prognosis and followed-up of patients with increased mortality.Keywords
This publication has 15 references indexed in Scilit:
- Antimicrobial Resistance Mechanisms and Genetic Diversity of Multidrug-Resistant Acinetobacter baumannii Isolated from a Teaching Hospital in MalaysiaMicrobial Drug Resistance, 2017
- Antimicrobial activity of novel 4 H -4-oxoquinolizine compounds against extensively drug-resistant Acinetobacter baumannii strainsInternational Journal of Antimicrobial Agents, 2017
- Phenotypic and molecular detection of the blaKPC gene in clinical isolates from inpatients at hospitals in São Luis, MA, BrazilBMC Infectious Diseases, 2016
- Molecular epidemiology of environmental and clinical carbapenemase-producing Gram-negative bacilli from hospitals in Guelma, Algeria: Multiple genetic lineages and first report of OXA-48 in Enterobacter cloacaeJournal of Global Antimicrobial Resistance, 2016
- Molecular Epidemiology of Multi-Drug Resistant Acinetobacter baumannii Isolated in Shandong, ChinaFrontiers in Microbiology, 2016
- Emergence of Oxacillinases in Environmental Carbapenem-Resistant Acinetobacter baumannii Associated with Clinical IsolatesMicrobial Drug Resistance, 2016
- Antimicrobial activity, cytotoxicity and chemical analysis of lemongrass essential oil (Cymbopogon flexuosus) and pure citralApplied Microbiology and Biotechnology, 2016
- Airborne Nosocomial Infections2016
- Rapid antimicrobial susceptibility test for identification of new therapeutics and drug combinations against multidrug-resistant bacteriaEmerging Microbes & Infections, 2016
- Clinical and Economic Evaluation of Multidrug-ResistantAcinetobacter baumanniiColonization in the Intensive Care UnitInfection & Chemotherapy, 2016